• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哮喘中的神经机制

Neural mechanisms in asthma.

作者信息

Barnes P J

机构信息

Department of Thoracic Medicine, National Heart & Lung Institute, London, UK.

出版信息

Br Med Bull. 1992 Jan;48(1):149-68. doi: 10.1093/oxfordjournals.bmb.a072531.

DOI:10.1093/oxfordjournals.bmb.a072531
PMID:1352167
Abstract

Neural control of the airways may be abnormal in asthma and neurogenic mechanisms may contribute to the pathophysiology of asthma. Cholinergic nerves are the predominant bronchoconstrictor pathway in airways and cholinergic neurotransmission may be increased in asthma by the effects of inflammatory mediators on afferent nerves (reflex effect) and on prejunctional receptors on postganglionic nerves. In addition there may be a defect in prejunctional M2-receptors on cholinergic nerves resulting in increased cholinergic neural effects. beta-Adrenoceptor function may be abnormal in asthmatic airways as a result of chronic inflammation, but alpha-receptors are probably unimportant in regulation of human airway tone. Inhibitory NANC nerves are the only bronchodilator pathway in human airways, and there is some evidence that the neurotransmitter is predominantly nitric oxide, although vasoactive intestinal peptide may be contributory. It is possible that i-NANC function may be abnormal in asthma as a consequence of inflammation. Unmyelinated sensory nerves contain a variety of potent inflammatory peptides, including substance P and neurokinin A, which might be released in chronic inflammation, particularly if there is a proliferation of these nerves, increased neuropeptide synthesis or reduced metabolism by neutral endopeptidase.

摘要

哮喘患者气道的神经控制可能异常,神经源性机制可能参与哮喘的病理生理过程。胆碱能神经是气道中主要的支气管收缩途径,在哮喘中,炎症介质对传入神经(反射效应)和节后神经节前受体的作用可能会增加胆碱能神经传递。此外,胆碱能神经节前M2受体可能存在缺陷,导致胆碱能神经效应增强。由于慢性炎症,哮喘气道中的β-肾上腺素能受体功能可能异常,但α受体在调节人类气道张力方面可能并不重要。抑制性非肾上腺素能非胆碱能(NANC)神经是人类气道中唯一的支气管舒张途径,有证据表明其神经递质主要是一氧化氮,尽管血管活性肠肽可能也有作用。炎症可能导致哮喘患者的抑制性NANC功能异常。无髓感觉神经含有多种强效炎症肽,包括P物质和神经激肽A,这些炎症肽可能在慢性炎症中释放,特别是在这些神经增殖、神经肽合成增加或中性内肽酶代谢减少的情况下。

相似文献

1
Neural mechanisms in asthma.哮喘中的神经机制
Br Med Bull. 1992 Jan;48(1):149-68. doi: 10.1093/oxfordjournals.bmb.a072531.
2
Autonomic innervation of human airways: structure, function, and pathophysiology in asthma.人类气道的自主神经支配:哮喘中的结构、功能及病理生理学
Neuroimmunomodulation. 1999 May-Jun;6(3):145-59. doi: 10.1159/000026376.
3
Cholinergic and neurogenic mechanisms in obstructive airways disease.阻塞性气道疾病中的胆碱能和神经源性机制。
Am J Med. 1986 Nov 14;81(5A):93-102. doi: 10.1016/0002-9343(86)90470-5.
4
The role of neuroeffector mechanisms in the pathogenesis of asthma.
Curr Allergy Asthma Rep. 2001 Mar;1(2):134-43. doi: 10.1007/s11882-001-0081-8.
5
[Airway autonomic nervous system dysfunction and asthma].[气道自主神经系统功能障碍与哮喘]
Nihon Kokyuki Gakkai Zasshi. 1999 Jan;37(1):3-9.
6
Airway inflammation and autonomic control.气道炎症与自主神经控制。
Eur J Respir Dis Suppl. 1986;147:80-7.
7
Non-adrenergic, non-cholinergic neural control of the airways.气道的非肾上腺素能、非胆碱能神经控制
Clin Exp Pharmacol Physiol. 1991 Oct;18(10):675-84. doi: 10.1111/j.1440-1681.1991.tb01380.x.
8
Overview of neural mechanisms in asthma.
Pulm Pharmacol. 1995 Aug-Oct;8(4-5):151-9. doi: 10.1006/pulp.1995.1020.
9
Neuroeffector mechanisms: the interface between inflammation and neuronal responses.神经效应器机制:炎症与神经元反应之间的界面
J Allergy Clin Immunol. 1996 Nov;98(5 Pt 2):S73-81; discussion S81-3.
10
[Regulation of the tracheobronchial and lung vascular system: innervation and receptors].[气管支气管和肺血管系统的调节:神经支配与受体]
Wien Klin Wochenschr. 1986 Nov 7;98(21):7013-25.

引用本文的文献

1
Potential pharmaceuticals targeting neuroimmune interactions in treating acute lung injury.针对神经免疫相互作用的潜在药物治疗急性肺损伤。
Clin Transl Med. 2024 Aug;14(8):e1808. doi: 10.1002/ctm2.1808.
2
Comorbidity of Neurally Mediated Syncope and Allergic Disease in Children.儿童神经介导性晕厥与过敏性疾病的共存。
Front Immunol. 2020 Aug 28;11:1865. doi: 10.3389/fimmu.2020.01865. eCollection 2020.
3
Stimulatory Effect of 5-Hydroxytryptamine (5-HT) on Rat Capsaicin-Sensitive Lung Vagal Sensory Neurons via Activation of 5-HT Receptors.
5-羟色胺(5-HT)通过激活5-HT受体对大鼠辣椒素敏感的肺迷走感觉神经元的刺激作用。
Front Physiol. 2019 May 28;10:642. doi: 10.3389/fphys.2019.00642. eCollection 2019.
4
Clinical efficacy and safety of anticholinergic therapies in pediatric patients.抗胆碱能疗法在儿科患者中的临床疗效与安全性。
Ther Clin Risk Manag. 2019 Mar 14;15:437-449. doi: 10.2147/TCRM.S161362. eCollection 2019.
5
Novel candidate genes important for asthma and hypertension comorbidity revealed from associative gene networks.从关联基因网络中揭示的对哮喘和高血压合并症重要的新型候选基因。
BMC Med Genomics. 2018 Feb 13;11(Suppl 1):15. doi: 10.1186/s12920-018-0331-4.
6
Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma.长效毒蕈碱拮抗剂在哮喘管理中的定位
Allergy Asthma Immunol Res. 2017 Sep;9(5):386-393. doi: 10.4168/aair.2017.9.5.386.
7
Future treatment for asthma.哮喘的未来治疗方法。
Eur Respir Rev. 2016 Mar;25(139):77-92. doi: 10.1183/16000617.0069-2015.
8
Is there a rationale and role for long-acting anticholinergic bronchodilators in asthma?长效抗胆碱能支气管扩张剂在哮喘中有作用机制和作用吗?
NPJ Prim Care Respir Med. 2014 Jul 17;24:14023. doi: 10.1038/npjpcrm.2014.23.
9
In vitro anticholinergic and antihistaminic activities of Acorus calamus Linn. leaves extracts.菖蒲叶提取物的体外抗胆碱能和抗组胺活性。
Afr J Tradit Complement Altern Med. 2012 Oct 1;10(1):95-101. eCollection 2012.
10
Neurally mediated airway constriction in human and other species: a comparative study using precision-cut lung slices (PCLS).神经介导的人类和其他物种气道收缩:使用精密切割肺切片 (PCLS) 的比较研究。
PLoS One. 2012;7(10):e47344. doi: 10.1371/journal.pone.0047344. Epub 2012 Oct 9.